‘Novel approach’ to treating Alzheimer’s disease discovered — it’s a gas
Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.
New study suggests ultrasound might be a promising treatment for Alzheimer’s disease
Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical trial has demonstrated the potenti
A Breath Away From a Cure: How Xenon Gas Could Transform Alzheimer’s Treatment
A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ability to mitigate brain damage and improve cognitive functions in mouse models.
Mountain climbing and treating Alzheimer's: Could xenon gas have potential?
In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped reduce levels of brain atrophy and neuroinflammation.
Inhaling this gas could help treat Alzheimer's disease, study suggests
Scientists have discovered that inhaling xenon gas can activate brain immune cells to break down Alzheimer's-related plaques and reduce inflammation. Successful mouse experiments are paving the way for human trials.
Xenon gas could protect against Alzheimer's disease: Mouse study
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- approach: using Xenon gas.
FIU News1d
Promising new drug candidate for Alzheimer’s
Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...
verywellhealth4d
Zunveyl: An Improved Alzheimer's Drug With Fewer Side Effects Will Be Available Soon
Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.
Rolling Out13d
Dopamine’s surprising breakthrough in Alzheimer’s treatment
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
Benzinga.com4d
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
FDA sets August 31, 2025, as the action date for Eisai and Biogen's Leqembi subcutaneous autoinjector application.
Monthly Prescribing Reference1d
Lecanemab SC Formulation Under Review for Early Alzheimer Disease
The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
National Alzheimer’s Association’s 10-year vision includes big changes in treatment and detection
Quality time takes on a whole new meaning after an Alzheimer’s diagnosis. “We just finished a two-week European River cruise, ...
Hosted on MSN4d
A unified approach to Alzheimer's: Key legislative wins for 2024
The NAPA Reauthorization Act extends the National Alzheimer's Plan through 2035, prioritizing healthy aging, risk reduction, ...